Placental Derived Mesenchymal Cells - Isolation, Processing and
Organized by the ISCT Lab Practices Committee
Chair: Eugenia Ioannidi, PhD, Laboratory Supervisor, Stem
Health Hellas, Greece
Speaker: Ornella Parolini,
PhD, Director, Research Centre E.Menni, Fondazione Poliambulanza,
- Provide a basic overview of the normal developmental biology of the human
- Provide a basic description of the structure of different placental regions.
- Describe and discuss the methods used to isolate stem/progenitor cells from
different placental tissues.
- Discuss methods and results regarding the characterization of
placenta-derived cells through in vitro studies, in terms of:
phenotype, differentiation potential, immunomodulatory properties.
- Discuss emerging insights on preclinical studies with placenta-derived
In recent years, scientists have revealed that the placenta is a valuable
source of cells for research and development of cell therapies. Indeed,
different cell populations which harbor both properties of stem/progenitor
cells, as well as immunomodulatory properties, have been isolated and
characterized from both human and animal placental tissues. Advances in this
field have also prompted researches to investigate the potential effects of
these cells in preclinical animal models of different diseases and clinical
applications, with encouraging results obtained to date.
This webinar will focus on the isolation, processing and characterization of
placenta-derived cells, with special emphasis on mesenchymal stromal/stem cells
that can be isolated from placental tissues. We will also address the most
significant achievements to date in the field of placental cell-based
This product is a downloadable PDF containing a link to the mp4 video recording of this presentation featuring the Power Point slides and audio recording.